cho_logo_symbol_border

Tag: SARS-CoV

Many ‘long Covid’ sufferers unable to fully work six months later

Many people suffering from “long Covid” are still unable to work at full capacity six months after infection, a large-scale survey of confirmed and suspected patients has found.

Read More

Study: Evidence based management guideline for the COVID-19 pandemic – Review article

By Maria Nicola, Niamh O’Neill, Catrin Sohrabi, Mehdi Khan, Maliha Agha, and Riaz Agha • Published 2020 Apr 11 Elsevier Public Health Emergency Collection COVID-19 has now been declared a pandemic. To date, COVID-19 has affected over 2.5 million people worldwide, resulting in over 170,000 reported deaths. Numerous preventative strategies and non-pharmaceutical interventions have

Read More

Study: SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

By Michael A. Johansson, PhD ; Talia M. Quandelacy, PhD, MPH ; Sarah Kada, PhD ; et al • Published January 7, 2021 JAMA NETWORK Question  What proportion of coronavirus disease 2019 (COVID-19) spread is associated with transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from persons with no symptoms? Findings  In this decision analytical model assessing multiple scenarios for

Read More

Study: Unclear but present danger: An asymptomatic SARS-CoV-2 carrier

By Xuejing Yu,  Dongchuan Ran,  Jinhui Wang,  Yuan Qin,  Ruishan Liu,  Xueli Shi,  Yiping Wang,  Chang Xie,  Jia Jiang, and Jianzhong Zhou • Published 2020 Jul 23 Genes & Diseases Superspreaders are critical infectious resources in multiple infectious diseases. They can be asymptomatic or present mild symptoms but can

Read More

Study: MERS, SARS, and Ebola: The Role of Super-Spreaders in Infectious Disease

Super-spreading occurs when a single patient infects a disproportionate number of contacts. The 2015 MERS-CoV, 2003 SARS-CoV, and to a lesser extent 2014–15 Ebola virus outbreaks were driven by super-spreaders.

Read More

 

Our Journey to $1B+ Valuation

 

Disrupting Healthcare Testing / Diagnostics Early Detection of Cancer,
Chronic Conditions, Disease, Unlocking Anti-Aging Genomics & Promoting Longevity.

 

FUNDING GOAL $20,000,000

Funding Goal $20,000,000

20%

Skip to content